Under construction – not a live service
Sign in
Taking people in FranceNo phase

Questionnaire to measure salt intake in patients with high blood pressure or kidney disease

Tests a questionnaire that estimates salt intake in adults with hypertension or kidney insufficiency.

Plain-language title generated from the registry record
Registry title: Food Frequency Questionnaire to Assess Sodium Intake

Key facts

Where
Lille, FranceSee the site

Where in France

  • Hôpital Huriez - Service Endocrinologie DiabétologieLille, FranceTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
University Hospital, Lille
Trial code
NCT05533645
Record updated
26 December 2025
Original description
EvalSel can precisely assess the salt intake of hospitalized patients in nephrology and cardiology or in medical consultation. It can determine salt consumption to the nearest gram.Read full original descriptionShow less

Development and Validation of a Food Frequency Questionnaire to Assess Sodium Intake in Hospitalized Patients or in Medical Consultation

EvalSel can precisely assess the salt intake of hospitalized patients in nephrology and cardiology or in medical consultation. It can determine salt consumption to the nearest gram.

The objectives of this food frequency questionnaire are to arrive at a precise dietary diagnosis and to quickly identify the dietary errors made by the patients.

EvalSel is useful for doctors to quickly obtain an assessment of the salt consumption of their patients, so they can refer them to dietitians if necessary. It can be used on the day of admission to hospital or during medical follow-ups to know the evolution of their consumption over the long term and improve their care.

Inclusion: Patients with high blood pressure, CKD stages 4-5 and patients free from any diseases; Patients over 18 years old; Patients in nephrology and cardiology consultation or recruited by CIC; Patients with health insurance; Patients willing to follow the full study.

Exclusion: Loss of salt by vomiting, diarrhea or sweating (intense sport or intense fever 3 days before urine collection) which can cause a decreasing natriuresis; Taking certain drugs like effervescent drugs, Gaviscon and Tolvaptan during the day of urine collection, as well as diuretics (unless they are taken long-term and the diuresis is stable) which can cause an increasing natriuresis; Modification of the therapeutic management of patients during the study period; Pregnant or breastfeeding women; Patients protected by law.

ClinicalTrials.gov NCT05533645